-
Product Insights
NewResistant Pseudomonas aeruginosa Infections – Drugs In Development, 2024
Empower your strategies with our Resistant Pseudomonas aeruginosa Infections – Drugs In Development, 2024 report and make more profitable business decisions. Pseudomonas aeruginosa has become an important cause of infection, especially in patients with compromised host defense mechanisms. It has an ability to rapidly develop resistance to multiple classes of antibiotics. It is the most common pathogen isolated from patients who have been hospitalized for more than one week. Signs and symptoms include pneumonia, fever, fatigue, itchy rash, bleeding ulcers, and...
-
Product Insights
NewPlague – Drugs In Development, 2024
Empower your strategies with our Plague – Drugs In Development, 2024 report and make more profitable business decisions. Plague is an infection caused by the bacterium Yersinia pestis. The organism is transmitted to humans who are bitten by fleas that have fed on infected rodents, or when human handle infected animals. Symptoms include headache, fatigue or malaise, muscle aches, fever and chills, abdominal pain, diarrhea and vomiting, shock, and bleeding from the mouth, nose, ectum, or under the skin. Treatment includes...
-
Product Insights
NewTyphoid Fever – Drugs In Development, 2024
Empower your strategies with our Typhoid Fever – Drugs In Development, 2024 report and make more profitable business decisions. Typhoid fever is an infection that causes diarrhea and a rash. It is most commonly due to a type of bacterium called Salmonella typhi. Symptoms include abdominal tenderness, agitation, chills, delirium, hallucinations, severe fatigue, and weakness. Treatment includes antibiotics and supportive therapy. The Typhoid Fever drugs in development market research report provide comprehensive information on the therapeutics under development for Typhoid Fever,...
-
Product Insights
NewBurkholderia Infections – Drugs In Development, 2024
Empower your strategies with our Burkholderia Infections – Drugs In Development, 2024 report and make more profitable business decisions. Burkholderia is a genus of Pseudomonadota whose pathogenic members include the Burkholderia cepacia complex, which attacks humans and Burkholderia mallei, responsible for glanders, a disease that occurs mostly in horses and related animals; Burkholderia pseudomallei, causative agent of melioidosis; and Burkholderia cepacia, an important pathogen of pulmonary infections in people with cystic fibrosis (CF). The Burkholderia Infections drugs in development market research...
-
Product Insights
NewGonorrhea – Drugs In Development, 2024
Empower your strategies with our Gonorrhea – Drugs In Development, 2024 report and make more profitable business decisions. Gonorrhea is a sexually transmitted disease (STD) caused by Neisseria gonorrhoeae bacterium. It can infect both males and females. The bacteria target the cells of the mucous membranes, including surfaces of the urethra, vagina, cervix, and endometrium, the lining of the eyelid, the throat, and fallopian tubes. Symptoms include painful urination, pus-like discharge from penis, increased vaginal discharge, abdominal pain, and pelvic pain....
-
Product Insights
NewBacterial Sepsis – Drugs In Development, 2024
Empower your strategies with our Bacterial Sepsis – Drugs In Development, 2024 report and make more profitable business decisions. Infection caused by bacteria known as bacterial sepsis. Sepsis is an emergency condition when existing infections in the body are triggered or body’s extreme response to an infection. Sepsis can result in multi organ damage and septic shock. It is also referred to as blood poisoning and septicemia. Flu, chest pain, paleness or bluish grey coloration of skin, rashes, SOB, fever, change...
-
Product Insights
NewMycobacterium avium Infections – Drugs In Development, 2024
Empower your strategies with our Mycobacterium avium Infections – Drugs In Development, 2024 report and make more profitable business decisions. Mycobacterium avium Infections is the most common cause of nontuberculosis mycobacterial species infections in humans, and the respiratory system is the most common site of infection. It consists of multiple nontuberculosis mycobacterial species (NTM). It is considered an opportunistic infection most observed in immunocompromised ones. It is caused by a group of bacteria most common species is M. avium and its...
-
Product Insights
NewMethicillin-Susceptible Staphylococcus aureus (MSSA) Infections – Drugs In Development, 2024
Empower your strategies with our Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections – Drugs In Development, 2024 report and make more profitable business decisions. Methicillin-susceptible Staphylococcus aureus (MSSA) is a bacterium that is resistant to many antibiotics. MSSA usually causes skin infections, but can also cause pneumonia and other serious types of infections. Symptoms include cellulitis, painful rashes, nausea and vomiting, fever, muscle aches, diarrhea, and abdominal pain. Predisposing factors include weakened immune systems, burns, and surgical wounds. The Methicillin-Susceptible Staphylococcus aureus (MSSA)...
-
Product Insights
NewOsteomyelitis – Drugs In Development, 2024
Empower your strategies with our Osteomyelitis – Drugs In Development, 2024 report and make more profitable business decisions. Osteomyelitis is an infection in a bone. Infections can reach a bone by traveling through the bloodstream or spreading from nearby tissue. Symptoms include fever, pain in the area of the infection, swelling, warmth and redness over the area of the infection, and irritability. Risk factors bone fracture, sickle cell disease, chemotherapy, diabetes, and peripheral arterial disease. Treatment includes surgery and oral antibiotics....
-
Product Insights
NewCholera – Drugs In Development, 2024
Empower your strategies with our Cholera – Drugs In Development, 2024 report and make more profitable business decisions. Cholera is an acute infectious disease caused by a bacterium, Vibrio cholera, which results in a painless, watery diarrhea in humans. Symptoms of cholera can begin as soon as a few hours or as long as five days after infection. Symptoms are often mild, they can be very serious. Signs and symptoms of cholera include rapid heart rate, loss of skin elasticity, low...